Early research (Phase 1)Study completedNCT04052971
What this trial is testing
To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer Harboring c-MET Dysregulation
Who this might be right for
Advanced Solid Tumors
Abion Inc 24